Lezoche E, Guerrieri M, Paganini A M, Baldarelli M, De Sanctis A, Lezoche G
Department of Surgery Paride Stefanini, II Clinica Chirurgica, University La Sapienza, Viale del Policlinico, 00161 Rome, Italy.
Br J Surg. 2005 Dec;92(12):1546-52. doi: 10.1002/bjs.5178.
Local excision after radiotherapy for node-negative low rectal cancer may be an alternative to radical excision. This study evaluated the results of local excision in patients with small (less than 3 cm in diameter) T2 and T3 distal rectal tumours following neoadjuvant therapy.
One hundred patients with rectal cancer (54 uT2 and 46 uT3 uN0 tumours) were enrolled. All patients underwent preoperative radiotherapy followed by local excision by means of transanal endoscopic microsurgery.
Definitive histological examination revealed nine pT1, 54 pT2 and 19 pT3 tumours. A complete response (R0) or microscopic residual tumour (R1mic) was found in three and 15 patients respectively. Minor complications occurred in 11 patients and major complications in two. At a median follow-up of 55 (range 7-120) months, the local failure rate was 5 per cent and metastatic disease was found in two patients. The cancer-specific survival rate at 90 months' follow-up was 89 per cent, and the overall survival rate 72 per cent. Salvage abdominoperineal resection was performed in three patients, two of whom were disease free at 15 and 19 months.
Treatment of small uT2 and uT3 uN0 rectal cancers with preoperative high-dose radiotherapy followed by transanal endoscopic microsurgery is an acceptable alternative to conventional radical resection.
对于淋巴结阴性的低位直肠癌,放疗后局部切除可能是根治性切除的一种替代方法。本研究评估了新辅助治疗后直径小于3 cm的T2和T3期低位直肠肿瘤患者行局部切除的结果。
纳入100例直肠癌患者(54例为uT2期,46例为uT3期uN0肿瘤)。所有患者均接受术前放疗,随后通过经肛门内镜显微手术进行局部切除。
最终组织学检查显示9例为pT1期肿瘤,54例为pT2期肿瘤,19例为pT3期肿瘤。分别有3例和15例患者达到完全缓解(R0)或镜下残留肿瘤(R1mic)。11例患者发生轻微并发症,2例发生严重并发症。中位随访时间为55个月(范围7 - 120个月),局部复发率为5%,2例患者出现转移性疾病。随访90个月时,癌症特异性生存率为89%,总生存率为72%。3例患者接受了挽救性腹会阴联合切除术,其中2例在术后15个月和19个月时无疾病生存。
术前大剂量放疗后行经肛门内镜显微手术治疗小的uT2和uT3期uN0直肠癌是传统根治性切除的一种可接受的替代方法。